Sam Altman, Dario Amodei, and other executives have said AI advances could weaken biosecurity barriers Executives from leading AI companies have joined biotechnology experts in an urgent call to mandate safety screening for synthetic DNA purchases. In a public letter addressed to the US Congress, the signatories argue that rapid advances in AI could increase the risk of biological weapons being developed. The appeal published earlier this week was signed by Google DeepMind’s Demis Hassabis,

Tag-uri: DNA